Sentences Generator
And
Your saved sentences

No sentences have been saved yet

"apheresis" Definitions
  1. withdrawal of blood from a donor's body, removal of one or more blood components (such as plasma, platelets, or white blood cells), and transfusion of the remaining blood back into the donor
"apheresis" Antonyms

131 Sentences With "apheresis"

How to use apheresis in a sentence? Find typical usage patterns (collocations)/phrases/context for "apheresis" and check conjugation/comparative form for "apheresis". Mastering all the usages of "apheresis" from sentence examples published by news publications.

The Connecticut patients, two males with acute myeloid leukemia, each received a platelet unit made from the same apheresis donation, collected in Massachusetts.
It can take up to two hours to extract platelets using an apheresis machine, said Dr. Richard Benjamin, chief medical officer for Cerus.
Plasma today is mostly collected via apheresis, a process where whole blood is extracted, spun in a centrifuge, and the plasma is skimmed off.
Twice a week, he sat for an hour in a Grifols Biomat centre, as an apheresis machine whirled, siphoning the plasma out of his blood.
People with homozygous FH may need LDL apheresis — a dialysis-like procedure that removes cholesterol from the blood — and has been found to lower LDL cholesterol by about 70% to 83%.
When collecting platelets for a transfusion, a donor's blood is drawn into an apheresis cell separator machine, which extracts platelets and returns the rest of the blood into the donor, according to the American Red Cross.
All of the collection sets used with the apheresis machines came from the same manufacturer, while two of three sets were traced to the same lot, the CDC reported without disclosing the name of the manufacturer.
Besides taking drugs, cholesterol patients often undergo a procedure called apheresis, which is as invasive as dialysis and involves using a machine that removes bad cholesterol over a period of between one and three hours, Amgen said.
The procedure, called apheresis, is similar to giving blood, except that the blood drawn from the patient is run through a machine to extract the plasma, and the red and white cells are then returned to the donor.
"This is the first time a PCSK9 inhibitor has shown in a clinical study that it reduced the frequency of apheresis therapy, an invasive, difficult to access, time-consuming and expensive treatment for some of the most difficult-to-treat patients," said Bill Sasiela, vice president of program direction at Regeneron.
Apheresis, which is a procedure where bad cholesterol is removed from the blood in a process similar to kidney dialysis, can take more than three hours and cost up to $100,000 for each patient per year in the United States or up to 60,000 euros ($67,218) in Germany, the companies said.
This puzzle was a bit of an experiment in that I tried to mix "trendy" fill like the above with fill that has (as the editing team aptly called it) an "intellectual vibe" — more obscure, yet valid entries that my nerdy self found interesting (like APHERESIS, IDIOLECT and BENJAMITE.) I don't recall seeing many themeless puzzles try this combination of fill, but the result is likely a bit of a tougher challenge than usual.
In addition to providing education in apheresis medicine for healthcare professionals, ASFA also now seeks to provide education to patients undergoing apheresis treatment.
In medicine, LDL apheresis is a form of apheresis, resembling dialysis, to eliminate the cholesterol-containing particle low-density lipoprotein (LDL) from the bloodstream.
The American Society for Apheresis (ASFA) is an organization of physicians, scientists, nurses, and allied health professionals whose mission is to advance apheresis medicine for patients, donors and practitioners through education, evidence-based practice, research and advocacy. ASFA represents a broad range of health care professionals involved in apheresis medicine including those practicing pathology, transplantation, hematology, oncology, neurology, rheumatology, nephrology, hepatology, gastroenterology, cardiology, and ophthamology. These health care providers are involved in the performance of therapeutic apheresis procedures including plasma exchange, red cell exchange, leukocytapheresis, plateletapheresis, photopheresis, LDL apheresis, and hematopoietic progenitor cell collection. ASFA also represents those physicians and allied health professionals involved in the collection of blood products from blood donors using apheresis instruments.
Disinfect, insert the cannula, pull out the cannula, dress the wound. The blue pressure cuff is controlled by the platelet apheresis machine in newer models. There are numerous types of apheresis.
The major activities of ASFA are member driven and educational, including publication of the Journal of Clinical Apheresis Special Issue: Clinical Applications of Therapeutic Apheresis: An Evidence Based Approach, publication of Principles of Apheresis Technology Textbook, publication of Therapeutic Apheresis: A Physician's Handbook, monthly apheresis educational webinar program and developing programming for the ASFA Annual Meeting. ASFA was formed in 1982. It grew from the merger of two organizations, the Society of Hemapheresis Specialists (SHS) and the original ASFA. The SHS was formed by nursing and allied health personnel, who were responsible for performing the donor and therapeutic procedures and operating the various blood cell separators.
In historical phonetics and phonology, the term "apheresis" is often limited to the loss of an unstressed vowel. The Oxford English Dictionary gives that particular kind of apheresis the name aphesis (; from Greek ἄφεσις).
Platelets collected by using apheresis at an American Red Cross donation center.
Apheresis (ἀφαίρεσις (aphairesis, "a taking away")) is a medical technology in which the blood of a person is passed through an apparatus that separates out one particular constituent and returns the remainder to the circulation. It is thus an extracorporeal therapy. The apheresis machine was invented by American medical technologist Herb Cullis in 1972. One of the uses of apheresis is for collecting stem cells.
Etrolizumab decreases lymphocytes trafficking, similar to vedolizumab (another integrin antagonist). A type of leukocyte apheresis, known as granulocyte and monocyte adsorptive apheresis, still requires large-scale trials to determine whether or not it is effective. Results from small trials have been tentatively positive.
The apheresis procedure typically lasts for 4–6 hours, depending on the donor's total blood volume.
FFP is made by centrifugation of whole blood or apheresis device followed by freezing and preservation.
It was formed provide educational and networking opportunities in the field of apheresis medicine that were not available and which were needed by the original members in order to advance the field. SHS became a national forum for the exchange of views and best practices and was the forerunner of the efforts directed toward apheresis practitioner certification. The original ASFA developed from a physician-scientist symposia. It was originally developed for the purpose to present scientific research on donor and therapeutic apheresis topics.
Hester is a member of the Oklahoma College for Women Hall of Fame, the Texas Women's Hall of Fame, and the Oklahoma Hall of Fame. She is a recipient of the Cohn de Laval Award for great scientific contributions to apheresis."Awards: Cohn De laval Award," World Apheresis Association. Accessed May 25, 2016.
Leukocyte apheresis is a medical device therapy (selective granulocyte/monocyte adsorptive {GMA} apheresis; GMDN code: 47306) for the treatment of inflammation of the colon. It works by removing from the blood a group of white blood cells called activated leukocytes that play a key role in the inflammatory stages of ulcerative colitis (UC). Selectively reducing these cells in the blood helps to reduce inflammation in the colon. Leukocyte apheresis can help UC patients with chronic, grumbling disease who are either unsuitable for, intolerant of, or failing on medicines described above.
The first apheresis symposium was held in Chicago in 1979, and was the first of annual symposia. The subsequent symposia were named the ASFA Symposia. Most of the initial Officers and Board of Directors of ASFA presented at these symposia, from which the structure of the organization grew. In 1982, John Verrier-Jones, became the first president of ASFA. He noted that the term “apheresis” had been in use since 1914, and that the appropriate terms was “apheresis”, not “pheresis” as was quite widely used at the time.
From fluid tissues such as blood, cells are extracted by bulk methods, usually centrifugation or apheresis. From solid tissues, extraction is more difficult. Usually, the tissue is minced and then digested with the enzymes trypsin or collagenase to remove the extracellular matrix (ECM) that holds the cells. After that, the cells are free floating, and extracted using centrifugation or apheresis.
In India, as per Ministry of Health the blood donation interval criteria for apheresis requires at least 48 hours interval after platelet/plasma - apheresis. The donation should not be done more than 2 times a week and should also be limited to 24 times in one year. Thirdly, additional tests may be required before becoming a donor for the first time. These tests may establish a platelet count.
Platelets collected by using apheresis at an American Red Cross donation center. Apheresis is a blood donation method where the blood is passed through an apparatus that separates out one particular constituent and returns the remainder to the donor. Usually the component returned is the red blood cells, the portion of the blood that takes the longest to replace. Using this method an individual can donate plasma or platelets much more frequently than they can safely donate whole blood.
The general term for a loss of sound segments in the field of linguistics is known as "elision". Other types of elision include the processes of apheresis, syncope, apocope, synizesis, and synaloepha.
Platelets collected by using apheresis at an American Red Cross donation center. Not all platelet transfusions use platelets collected by automated apheresis. The platelets can also be separated from donations of whole blood collected in a traditional blood donation, but there are several advantages to separating the platelets at the time of collection. The first advantage is that the whole-blood platelets, sometimes called "random" platelets, from a single donation are not numerous enough for a dose to give to an adult patient.
Symptoms are usually sudden in onset and self-limiting, most often resolving within 2 weeks. IVIG therapy is the primary treatment. Additionally, PTP is an American Society for Apheresis Category III indication for plasmapheresis.
The risks of a complication depend on patient characteristics, health care providers, and the apheresis procedure, and the colony-stimulating factor used (G-CSF). G-CSF drugs include filgrastim (Neupogen, Neulasta), and lenograstim (Graslopin).
In phonetics and phonology, apheresis (; ) is the loss of one or more sounds from the beginning of a word, especially the loss of an unstressed vowel, thus producing a new form called an aphetism ().
On 31 July 2013 the European Commission approved lomitapide as an adjunct to a low- fat diet and other lipid-lowering medicinal products with or without low density lipoprotein (LDL) apheresis in adult patients with HoFH.
New cases are generally offered genetic counseling. Homozygous FH often does not respond to medical therapy and may require other treatments, including LDL apheresis (removal of LDL in a method similar to dialysis) and occasionally liver transplantation.
Blood donation pictogram Blood donation center at the University Hospital of Basel, Switzerland. From left to right: Two cell separators for apheresis, secluded office for pre-donation blood pressure measurement and blood count, and on the right, chairs for whole blood donations. A blood donation occurs when a person voluntarily has blood drawn and used for transfusions and/or made into biopharmaceutical medications by a process called fractionation (separation of whole-blood components). Donation may be of whole blood, or of specific components directly (the latter called apheresis).
The basic principles of automatic platelet apheresis are the same as in the manual procedure, but the whole procedure is performed by a computer-controlled machine. Since the donor's blood is processed in a sterile single-use centrifuge, the unwanted components can be returned to the donor safely. This allows the apheresis machine to repeat the draw-centrifuge-return cycle to obtain more platelets. The bulk of the machine and the length of the donation process means most platelet donations are done in blood centers instead of mobile blood drives.
Whole blood donors can donate at a mobile blood drive or any of the nine Donor Centres. Plasma and platelet donations require an apheresis machine and so can only be made at nine Donor Centres with these facilities.
Apheresis comes from Greek ἀφαίρεσις aphairesis, "taking away" from ἀφαίρέω aphaireo from ἀπό apo, "away" and αἱρέω haireo, "to take". Aphetism comes from Greek ἄφεσις aphesis, "letting go" from ἀφίημι aphiemi from ἀπό apo, "away" and ἵημι híemi, "send forth".
Synchronic apheresis is more likely to occur in informal speech than in careful speech: 'scuse me vs. excuse me, How 'bout that? and How about that? It typically supplies the input enabling acceptance of apheresized forms historically, such as especially > specially.
However, the risks of infection are higher in low income countries. Packed red blood cells are produced from whole blood or by apheresis. They typically last for three to six weeks. The widespread use of packed red blood cells began in the 1960s.
Although bone marrow is not an organ or a component of an organ, the act made paying bone marrow donors punishable by up to 5 years in prison. At the time the act was passed, donating bone marrow involved a painful and risky medical procedure. In the years after the act was passed, a new procedure (apheresis) made it possible to harvest bone marrow cells through a non-surgical procedure similar to the donation of blood components such as platelets or plasma. The Institute for Justice lawsuit argued that the development of apheresis meant that donors who gave bone marrow through blood donation should be allowed to receive compensation.
Erythrocytapheresis is an apheresis procedure by which erythrocytes (red blood cells) are separated from whole blood. It is an extracorporeal blood separation method whereby whole blood is extracted from a donor or patient, the red blood cells are separated, and the remaining blood is returned to circulation.
Bacterial infections are relatively more common with platelets as they are stored at warmer temperatures. Platelets can be produced either from whole blood or by apheresis. They keep for up to five to seven days. Platelet transfusions came into medical use in the 1950s and 1960s.
A blood product is any therapeutic substance prepared from human blood. This includes: whole blood; blood components; and plasma derivatives. Whole blood is not commonly used in transfusion medicine. Blood components include: red blood cell concentrates or suspensions; platelets produced from whole blood or via apheresis; plasma; and cryoprecipitate.
No more than 50% of a donor's platelets are ever extracted in one sitting, and they can be replenished by the body in about three days. Most newer apheresis machines can separate a maximum donation of platelets in about 60 to 120 minutes depending on the donor's health condition.
In November 2013, the first Plasmavie lounge specialized in collecting plasma opened its doors in Trois-Rivières. Since then, Héma-Québec has opened additional Plasmavie centres in Sherbrooke, Gatineau and Saguenay. The Saguenay and Gatineau centres also have space dedicated to whole blood donations. Plasmavie centres collect plasma by apheresis.
A hematoma caused by a dislodged needle during a plateletpheresis donation. Adverse conditions that can happen during a plateletpheresis donation are hypocalcemia, hematoma formation, and vasovagal reactions. The risk of these conditions happening can be reduced or prevented by pre-donation education of the donors and change of apheresis machine configuration.
Blood is drawn from a peripheral vein in a majority of patients, but a central line to the jugular, subclavian, and femoral veins may be used. Adverse reactions during apheresis were experienced in 20% of women and 8% of men, these adverse events primarily consisted of numbness/tingling, multiple line attempts, and nausea.
A single line cartridge based, centrifuge machine. Collecting a 'double unit' in this instance. The separation of individual blood components is done with a specialized centrifuge (see apheresis). The earliest manual forms of thrombapheresis are done by the separation of platelets from multiple bags of whole blood collected from donors or blood sellers.
Tailored Leukapheresis (TLA) treatment is an apheresis immunotherapy for selective removal of disease-causing pro-inflammatory cells extracorporeally, which has therapeutic application in various IMIDs that are caused and maintained by inflammation. TLA utilises the natural affinity of chemokines and chemokine receptors to selectively attract, bind, and deplete circulating pro-inflammatory cells en route to the site of inflammation. It is the first, and hitherto novel, apheresis technology with a demonstrated efficacy in targeting and removing selected leukocytes while leaving all other blood cells unaffected. The immunotherapy has been evaluated in a Phase I/II placebo- controlled clinical trial, where all primary and secondary clinical endpoints were met and the treatment showed an absence of any side effects of clinical significance.ClinicalTrials.
This process is sometimes done as automated apheresis, where the centrifuging and mixing take place at the donation site. Most blood banks utilize automated centrifugation systems to wash or volume reduce the blood products they produce and distribute. The other options is using the person's own blood. This is known as autologous blood transfusion.
Platelets can be produced either from whole blood donations or by apheresis. They keep for up to five to seven days. Platelet components can have had the white blood cells partially removed (leucodepleted) which decreases the risk of having a transfusion reaction. They can be treated with ultraviolet light which decreases the risk of transmission of certain infections.
The result may be doublets, such as especially and specially, or the pre-apheresis form may fail to survive (Old French eschars > English scarce). An intermediate status is common in which both forms continue to exist but lose their transparent semantic relationship: abate 'decrease, moderate', with bate now confined to the locution with bated breath 'with breath held back'.
Consequently, the development of pathogen inactivation/reduction technologies for blood products has been an ongoing effort in the field of transfusion medicine. A new procedure for the treatment of individual units of single-donor (apheresis) or whole blood–derived, pooled, platelets has recently been introduced. This technology uses riboflavin and light for the treatment of platelets and plasma.
Intermittent flow centrifugation works in cycles, taking blood, spinning/processing it and then giving back the unused parts to the donor in a bolus. The main advantage is a single venipuncture site. To stop the blood from coagulating, anticoagulant is automatically mixed with the blood as it is pumped from the body into the apheresis machine.
Plasma and platelets for transfusion are also collected by automated plateletpheresis. Collections take place at fixed sites, but SANBS also collects blood on mobile blood drives at community locations such as shopping centres. The blood is then processed into components at seven processing locations throughout South Africa. During 2008, SANBS collected 718,962 donations of Whole Blood and 11,657 donations of apheresis platelets.
Homozygous FH is harder to treat. The LDL(low Density Lipoprotein) receptors are minimally functional, if at all. Only high doses of statins, often in combination with other medications, are modestly effective in improving lipid levels. If medical therapy is not successful at reducing cholesterol levels, LDL apheresis may be used; this filters LDL from the bloodstream in a process reminiscent of dialysis.
This mobilizes stem cells to travel from the bone marrow into the circulating blood. The stem cells are collected through a procedure called apheresis, which is similar to the process used in platelet donation. A cell separating machine filters out the stem cells, which can then be infused into the recipient. Today, PBSC is requested approximately 80 percent of the time.
This process is called apheresis, and it is often done with a machine specifically designed for this purpose. This process is especially common for plasma and platelets. For direct transfusions a vein can be used but the blood may be taken from an artery instead. In this case, the blood is not stored, but is pumped directly from the donor into the recipient.
These reactions tend to cause tingling in the lips, but may cause convulsions, seizure, hypertension, or more serious problems. Donors are sometimes given calcium supplements during the donation to prevent these side effects. In apheresis procedures, the red blood cells are returned. If this is done manually and the donor receives the blood from a different donor, a transfusion reaction can take place.
The Blood Centre is licensed by the Drugs Controller General of India for blood components and apheresis procedures. The centre has also been designated as Regional Blood Transfusion Centre by the Government of India. The Department conducts Post-graduate Course (MD) in Transfusion Medicine. Further, a 2-year Post-graduate Diploma in Blood Banking Technology is also conducted for science graduates.
Peripheral blood stem cells Peripheral blood stem cells are now the most common source of stem cells for HSCT. They are collected from the blood through a process known as apheresis. The donor's blood is withdrawn through a sterile needle in one arm and passed through a machine that removes white blood cells. The red blood cells are returned to the donor.
Liz Szabo for USA Today July 24, 2015 FDA approves new cholesterol drug - at $14,600 a year Pharmacy benefit managers continued expressing their concerns, as did insurance companies and some doctors, who were especially concerned over the price, in light of the fact that the FDA approval was based on lowering cholesterol alone, and not on better health outcomes, such as fewer heart attacks or longer life. The current treatment for people with very high cholesterol that cannot be controlled with diet or statins is apheresis, which is similar to dialysis in that a person visits a clinic each month and his or her blood is mechanically filtered, in this case to remove LDL cholesterol. That treatment costs $8000 per month, or $96,000 per year. The price of alirocumab was determined based in part on making apheresis no longer necessary.
On March 6, 2015, the United States Food and Drug Administration authorized use of Lixelle Beta 2-microglobulin Apheresis Column, the first device to treat Haemodialysis-associated amyloidosis (DRA) developed and produced by Kaneka Corporation. The Lixelle Column system is used for helping patient to eliminate agents that cause inflammation. The system is used in treatment of HIV, arthritis, cholesterol management and ulcerative colitis.
To create the vaccine, blood is drawn from the patient and monocytes specific to the patient are separated from the blood via apheresis. Dendritic cells are then derived by adding cytokines to the extracted monocytes. The dendritic cells are then fused with tumor cells through electrofusion, creating a "hybrid cell" of tumor and dendritic cells. These hybrid cells are then injected back into the patient.
Aspirin may be beneficial, but it has only been tested in patients who carry the apolipoprotein(a) gene minor allele variant, (rs3798220). A recent meta-analysis suggests that atorvastatin also may lower Lp(a) levels. In severe cases, such as familial hypercholesterolemia or treatment-resistant hypercholesterolemia, lipid apheresis may dramatically reduce Lp(a). The goal of the treatment is to reduce levels to below 50 mg/dL.
LDL apheresis works by leading venous blood through a column containing beads coated with antibodies to apolipoprotein B (the main protein of LDL particles), dextran sulfate cellulose beads, modified polyacrylate beads, or by precipitating LDL with heparin at low pH, double membrane filtration or immunoadsorption utilizing Lp(a)-specific antibodies. In all cases (apart from polyacrylate absorption), plasma is separated from cells by a cell separator.
Peripheral blood mononuclear cells (PBMC) are then separated and collected. The products of leukocyte apheresis are then transferred to a cell-processing center. In the cell processing center, specific T cells are stimulated so that they will actively proliferate and expand to large numbers. To drive their expansion, T cells are typically treated with the cytokine interleukin 2 (IL-2) and anti-CD3 antibodies.
Manual apheresis is extremely rare in the developed world because of this risk and automated procedures are as safe as whole blood donations. The final risk to blood donors is from equipment that has not been properly sterilized.Global AIDS Crisis: A Reference Handbook, Richard G. Marlink, Alison G. Kotin, p. 16 , ABC-CLIO In most cases, the equipment that comes in direct contact with blood is discarded after use.
Some blood banks maintain records of the estimated number of platelets in each unit. Current requirements in the US stipulate that a unit of apheresis platelets must contain at least 3.0 x1011 platelets. In England only 1% of adult platelet components are tested to check the number of platelets meet the minimum required standard of 2.4 x 1011 platelets. Only components that contain fewer than 1.6 x 1011 platelets are discarded.
A Hickman line two-lumen catheter inserted on the patient's left side. Scars at the base of the neck indicate the insertion point into the left jugular vein. A Hickman line is a central venous catheter most often used for the administration of chemotherapy or other medications, as well as for the withdrawal of blood for analysis. Some types are used mainly for the purpose of apheresis or dialysis.
Venous access is any method used to access the bloodstream through the veins, either to administer intravenous therapy (e.g. medication, fluid), parenteral nutrition, to obtain blood for analysis, or to provide an access point for blood-based treatments such as dialysis or apheresis. Access is most commonly achieved via the Seldinger technique, and guidance tools such as ultrasound and fluoroscopy can also be used to assist with visualizing access placement.
Five Points of Life Foundation is a support affiliate of LifeSouth Community Blood Centers, a nonprofit 501(c)(3) charitable organization. The Five Points of Life Foundation educates and raises awareness of the five ways to share life with others through the donation of blood, apheresis, marrow, cord blood, organ and tissue. The Foundation works with blood centers, organ procurement organizations, marrow registries and community organizations to educate citizens about donation.
Canadian Plasma Resources is a source member of the Plasma Protein Therapeutics AssociationCurrent Members - PPTA and its facilities are certified through the International Quality Plasma Program. CPR plasma collection facilities are located in Saskatoon and Moncton. Plasma collection is done through automated apheresis. To ensure donor and product safety each center is operated under the responsibility of a licensed physician and certain tasks are delegated by the physician to registered nurses.
Continuous flow centrifugation (CFC) historically required two venipunctures as the "continuous" means the blood is collected, spun, and returned simultaneously. Newer systems can use a single venipuncture. The main advantage of this system is the low extracorporeal volume (calculated by volume of the apheresis chamber, the donor's hematocrit, and total blood volume of the donor) used in the procedure, which may be advantageous in the elderly and for children.
There are two types of manual platelet apheresis. Platelet-rich plasma (PRP) is widely used in North America and buffy coat (BC) is more widely used in Europe. Plasma can be collected simultaneously with a platelet donation. Platelets are the clotting cells of the blood, and when donated, frequently go to cancer patients, because due to chemotherapy many cancer patients are unable to generate enough platelets of their own.
In December 2011, the Ninth Circuit Court of Appeals ruled unanimously that donors giving bone marrow via apheresis were eligible for compensation. In November 2013, the federal government proposed a regulation that would change legal definitions to cover bone marrow regardless of how it is obtained. This would have the effect of keeping the ban on compensating donors in place. As of July 2014, the proposal was still under review.
Plasmapheresis is frequently used to collect source plasma that is used for manufacturing into medications much like the plasma from whole blood. Plasma collected at the same time as plateletpheresis is sometimes called concurrent plasma. Apheresis is also used to collect more red blood cells than usual in a single donation (commonly known as "double reds") and to collect white blood cells for transfusion. A relatively large needle is used for blood donations.
An exchange transfusion is a blood transfusion in which the patient's blood or components of it are exchanged with (replaced by) other blood or blood products. The patient's blood is removed and replaced by donated blood or blood components. This exchange transfusion can be performed manually or using a machine (apheresis). Most blood transfusions involve adding blood or blood products without removing any blood, these are also known as simple transfusions or top-up transfusions.
Daniel Wallace and Adam Selkowitz founded Lupus LA, an organization that raises money for Lupus research and patient care. Wallace served on the Medical Executive Committee for the American Society for Apheresis from 1987-1989. He was Co-Chairman (1999-2000) and Vice President (1999-2000) the Lupus Foundation of America and served on the National Medical Advisory Board. He now serves on the Board of Directors of the Lupus Research Alliance and Lupus Therapeutics.
Platelets have a life span of 5 to 9 days. Because of this, the U.S. Food and Drug Administration (FDA) expires transfuse-able platelets 5 days post-collection. Typically, hPL is produced from expired platelets that have been stored in frozen conditions no later than 7 days post-collection. hPL is created from single or pooled donor-donated platelets isolated from whole blood or by apheresis, distributed in a standard platelet collection bag.
She was one of the developers of IBM 2997, the computerized blood cell separator. The separator is "used in diagnosing red and white blood cells and platelets and the enhancement of cells to combat tumors." Hester served on the editorial boards of the Journal of Clinical Apheresis, the Journal of the American Medical Association, and Plasma Therapy and Transfusion Technology. She has contributed to over 25 books and over 125 other writings.
The second excerpt is from the epic of Digenes Akritas (manuscript E), possibly dating originally to the 12th century. This text is one of the earliest examples of Byzantine folk literature, and includes many features in line with developments in the demotic language. The poetic metre adheres to the fully developed Greek 15-syllable political verse. Features of popular speech like synezisis, elision and apheresis are regular, as is recognized in the transcription despite the conservative orthography.
A number of less common complications of blood donation are known to occur. These include arterial puncture, delayed bleeding, nerve irritation, nerve injury, tendon injury, thrombophlebitis, and allergic reactions. Donors sometimes have adverse reactions to the sodium citrate used in apheresis collection procedures to keep the blood from clotting. Since the anticoagulant is returned to the donor along with blood components that are not being collected, it can bind the calcium in the donor's blood and cause hypocalcemia.
If apheresis is not available, fresh frozen plasma can be infused, but the volume that can be given safely is limited due to the danger of fluid overload. Plasma infusion alone is not as beneficial as plasma exchange. Corticosteroids (prednisone or prednisolone) are usually given. Rituximab, a monoclonal antibody aimed at the CD20 molecule on B lymphocytes, may be used on diagnosis; this is thought to kill the B cells and thereby reduce the production of the inhibitor.
Since they are stored at room temperature in nutritive solutions, they are at relatively high risk for growing bacteria. US Food and Drug Administration scientist prepares blood donation samples for testing Some blood banks also collect products by apheresis. The most common component collected is plasma via plasmapheresis, but red blood cells and platelets can be collected by similar methods. These products generally have the same shelf life and storage conditions as their conventionally-produced counterparts.
Immunophenotyping will reveal cells that are CD3, a protein found on T cells, and help further distinguish the maturity of the T cells. Genetic analysis including karyotyping may reveal specific abnormalities that may influence prognosis or treatment, such as the Philadelphia translocation. Management can include multiple courses of chemotherapy, stem cell transplant, and management of associated problems, such as treatment of infections with antibiotics, and blood transfusions. Very high white cell counts may also require cytoreduction with apheresis.
Units can not be refrigerated as this causes platelets to change shape and lose function. Storage at room temperature provides an environment where any bacteria that are introduced to the blood component during the collection process may proliferate and subsequently cause bacteremia in the patient. Regulations are in place in the United States that require products to be tested for the presence of bacterial contamination before transfusion. Platelets collected by using apheresis at an American Red Cross donation center.
When an apheresis system is used for therapy, the system is removing relatively small amounts of fluid (not more than 10.5 mL/kg body weight). That fluid must be replaced to keep correct intravascular volume. The fluid replaced is different at different institutions. If a crystalloid like normal saline (NS) is used, the infusion amount should be triple what is removed as the 3:1 ratio of normal saline for plasma is needed to keep up oncotic pressure.
Unusually low calcium can cause more serious problems such as fainting, nerve irritation and short-duration tetany. Such an acute hypocalcaemia is usually due to low calcium levels prior to donation, aggravated by the anticoagulant. Hypocalcaemia can be curtailed by modestly increasing dietary calcium intake in the days prior to donation. Serious problems are extremely rare, but apheresis donors are typically not allowed to sleep during the long donation process so that they can be monitored.
In 2018, UC San Diego Health opened the new 156,000-square-foot Koman Family Outpatient Pavilion in La Jolla. The facility includes eight surgery suites, basic and advanced imaging, physical therapy and pain management, as well as infusion and apheresis services. Additionally, long-range plans are underway to modernize and expand UC San Diego Medical Center in Hillcrest. The Hillcrest hospital will be completely renovated or replaced on the same site before 2030, when it will fail to meet seismic safety standards.
Guidelines issued by the European Paediatric Study Group for HUS recommend rapid administration of plasma exchange or plasma infusion (PE/PI), intensively administered daily for 5 days and then with reducing frequency. However, the American Society for Apheresis offers a "weak" recommendation for plasma exchange to treat aHUS, due to the "low" or "very low" quality of evidence supporting its use. Although some patients experienced improvements in red blood cell and platelet counts, plasma therapies generally did not result in full remission.
The cells in which the mutations are induced ex vivo are filtered out from lymphocytes by apheresis to produce analogous lentiviral engineered CD4+ T-cells. These are re-infused into the body as a single dose of 1 X 1010 gene modified analogous CD4+ T-cells. A viral vector is used to deliver the ZFNs that induce the desired mutation into the cells. Conditions that promote this process are carefully monitored ensuring the production of CCR5 strain HIV-resistant T cells.
The use of PF24 has been accompanied by a decrease in the incidence of TRALI—a roughly 50% reduction in reported cases. Long-term studies on the effectiveness of PF24 in massive transfusion have not been conducted. This does not address the question of risk from plasma in other components, particularly apheresis platelets. Removing multiparous women from this limited donor pool would likely cause too great a shortage of platelets, resulting in more deaths (due to hemorrhage) than are seen due to TRALI after platelet infusion.
In 2019, Feinberg led the establishment of the world's first registry-integrated stem cell collection center, based at Gift of Life's headquarters in Boca Raton, Florida. There were two reasons for this new facility. First, Feinberg wanted to re-engineer the donor experience, providing apheresis services in a non-hospital setting that provided donors with all the amenities of a spa-like experience. Second, to expedite the time to transplant for patients, by limiting the collection center solely to peripheral blood stem cell collections for the registry.
In the United States it refers to the fluid portion of one unit of whole blood that has been centrifuged, separated, and frozen solid at or colder within eight hours of collection from whole blood donation or was otherwise collected via apheresis device. The phrase "FFP" is often used to mean any transfused plasma product. The other commonly transfused plasma, plasma frozen within 24 hours after phlebotomy (PF24), has similar indications as those for FFP. PF24 has slightly lower levels of Factors V and VIII than FFP.
The change in the recipient's platelet count after transfusion is termed the "increment" and is calculated by subtracting the pre-transfusion platelet count from the post-transfusion platelet count. Many factors affect the increment including the recipient's body size, the number of platelets transfused, and clinical features that may cause premature destruction of the transfused platelets. When recipients fail to demonstrate an adequate post- transfusion increment, this is termed platelet transfusion refractoriness. Platelets, either apheresis-derived or random-donor, can be processed through a volume reduction process.
Because a large amount of blood (seven to ten litres) is processed during apheresis, donors may experience adverse effects from changes in fluid balance. An alternative approach, more commonly used in the United Kingdom, is to combine the buffy coats (the fraction of blood containing white blood cells) from multiple routine blood donations to create a blood product containing a high amount of granulocytes. Once collected, granulocytes have a 24-hour shelf life. It is recommended that they are transfused within a few hours of collection.
Jon Poling is an American physician currently practicing in Athens, Georgia where he has worked at Athens Neurological Associates since 2001. He has also worked at Athens Regional Medical Center as the medical director of their apheresis unit since 2002. His area of expertise is autoimmune neurological disorders such as multiple sclerosis and neuromuscular disorders such as neuropathy or Myasthenia Gravis. He is the father of Hannah Poling, who received an injury compensation from the VICP in 2008 because Hannah manifested encephalopathy after being vaccinated by MMR.
Physicians may recommend patients to undergo autologous stem cell treatment after initial chemotherapy as most patients with PTCL will relapse. It is also used when the lymphoma does not respond well to the initial treatment (refractory lymphoma). Patient's blood are drawn out from the body prior to chemotherapy treatment and stem cells are filtered out through a process called apheresis. Stem cells are infused back into the patient's bloodstream after chemotherapy treatment and replaces the damaged bone marrow or stem cells that are destroyed by the chemotherapy treatment.
Blood donation centers will sometimes collect only plasma from AB donors through apheresis, as their plasma does not contain the antibodies that may cross react with recipient antigens. As such, AB is often considered the "universal donor" for plasma. Special programs exist just to cater to the male AB plasma donor, because of concerns about transfusion related acute lung injury (TRALI) and female donors who may have higher leukocyte antibodies. However, some studies show an increased risk of TRALI despite increased leukocyte antibodies in women who have been pregnant.
Erythrocytapheresis can also be used for blood donations. The procedure is commonly done using automated red blood cell collection which involves the removal of two units of red blood cells. This includes either two standard units of red blood cells or one unit plus of red blood cells and another of either plasma or platelets. The advantage to the donor is the use of smaller needles and saline compensation, as well as more convenient donating schedules (the no-donation period following apheresis is twice as long as that for a single unit).
The organization predicted that allowing compensation would increase the pool of available donors, and claimed that 3,000 Americans die each year while waiting for compatible marrow donors. Critics argued that allowing compensation could reduce donation, increase the risk of disease, and lead to exploitation of the poor. In December 2011, the Ninth Circuit Court of Appeals ruled unanimously that donors giving bone marrow via apheresis were eligible for compensation. In November 2013, the federal government proposed a regulation that would change legal definitions to cover bone marrow regardless of how it is obtained.
The JCRC has plans to build an international research hospital worth US$120 million in collaboration with Tokushukai Medical Group of Japan. Commitment for 70 percent funding has been obtained from the African Development Bank (AfDB). In March 2018, the institution procured an Apheresis machine, which enables healthcare personnel to extract only those selected blood components from a donor's or patient's blood, and return the non-selected components back into the bloodstream of the donor/patient. This technique is of particular significance and utility, when treating patients with sickle cell disease and HIV/AIDS.
Due to the high mortality of untreated TTP, a presumptive diagnosis of TTP is made even when only microangiopathic hemolytic anemia and thrombocytopenia are seen, and therapy is started. Transfusion is contraindicated in thrombotic TTP, as it fuels the coagulopathy. Since the early 1990s, plasmapheresis has become the treatment of choice for TTP. This is an exchange transfusion involving removal of the person's blood plasma through apheresis and replacement with donor plasma (fresh frozen plasma or cryosupernatant); the procedure must be repeated daily to eliminate the inhibitor and abate the symptoms.
Apheresis platelets are collected using a mechanical device that draws blood from the donor and centrifuges the collected blood to separate out the platelets and other components to be collected. The remaining blood is returned to the donor. The advantage to this method is that a single donation provides at least one therapeutic dose, as opposed to the multiple donations for whole- blood platelets. This means that a recipient is not exposed to as many different donors and has less risk of transfusion-transmitted disease and other complications.
Hemodialysis, also spelled haemodialysis, or simply dialysis, is a process of purifying the blood of a person whose kidneys are not working normally. This type of dialysis achieves the extracorporeal removal of waste products such as creatinine and urea and free water from the blood when the kidneys are in a state of kidney failure. Hemodialysis is one of three renal replacement therapies (the other two being kidney transplant and peritoneal dialysis). An alternative method for extracorporeal separation of blood components such as plasma or cells is apheresis.
The dressing applied to a donor's arm after giving blood Following the donation (and subsequent dressing of the wound), donors are invited to refreshments. This period serves two vital purposes: to replace certain lost fluids, and to allow staff to monitor the donor's wellbeing. Donations can also be taken by machines called cell separators, usually in larger blood donation centres located in city centres. These machines use a process called apheresis to collect either blood plasma only, or plasma and platelets, the other blood cells being returned to the patient.
Depiction of adoptive cell transfer therapy with CAR-engineered T cells The first step in the production of CAR-T cells is the isolation of T cells from human blood. CAR-T cells may be manufactured either from the patient's own blood, known as an autologous treatment, or from the blood of a healthy donor, known as an allogeneic treatment. The manufacturing process is the same in both cases; only the choice of initial blood donor is different. First, leukocytes are isolated using a blood cell separator in a process known as leukocyte apheresis.
The institute has completed more than 3,000 successful transplants. The Rogosin Institute Comprehensive Lipid Control Center is a research and treatment center for adults and children with cholesterol and triglyceride disorders that provides a full range of diagnostic and individualized treatment plans. The institute pioneered clinical research of LDL apheresis in the early 1980s, which led to the adoption of the procedure to treat patients with the genetic form of extremely high cholesterol. Physicians at the institute treat hypertension in patients with hypertension alone and in those with both hypertension and kidney disease.
In English orthography, the letter ⟨k⟩ normally reflects the pronunciation of [] and the letter ⟨g⟩ normally is pronounced or "hard" , as in goose, gargoyle and game; or "soft" , generally before or , as in giant, ginger and geology; or in some words of French origin, such as rouge, beige and genre. However, silent ⟨k⟩ and ⟨g⟩ occur because of apheresis, the dropping of the initial sound of a word.’Scuse me, squire – ’tis just aphaeresis, Macmillan Dictionary Blog These sounds used to be pronounced in Old and Middle English.
Pooling of whole blood platelets is often done in an "open" system where the platelet containers are connected in a way that could expose the platelets to air, and pooled platelets must be transfused promptly so that any contamination does not have time to grow. Problems with apheresis include the expense of the equipment used for collection. Whole blood platelets also do not require any additional donor recruitment, as they can be made from blood donations that are also used for packed red blood cells and plasma components.
In 2009, a public interest law firm (The Institute for Justice) sued to allow donors to be compensated for giving bone marrow. The firm argued that the development of apheresis meant that donors who gave bone marrow through blood donation should be allowed to receive compensation. The organization predicted that allowing compensation would increase the pool of available donors, and claimed that 3,000 Americans die each year while waiting for compatible marrow donors. Critics argued that allowing compensation could reduce donation, increase the risk of disease, and lead to exploitation of the poor.
NOTA made it illegal to compensate organ donors, but did not prevent payment for other forms of donations (such as human plasma, sperm, and egg cells). Although bone marrow is not an organ or a component of an organ, the act made paying bone marrow donors illegal. At the time the act was passed, donating bone marrow involved a painful and risky medical procedure. In the years after the act was passed, a new procedure (apheresis) made it possible to harvest bone marrow cells through a non- surgical procedure similar to blood donation.
Given that FH is present from birth and atherosclerotic changes may begin early in life, it is sometimes necessary to treat adolescents or even teenagers with agents that were originally developed for adults. Due to safety concerns, many physicians prefer to use bile acid sequestrants and fenofibrate as these are licensed in children. Nevertheless, statins seem safe and effective, and in older children may be used as in adults. An expert panel in 2006 advised on early combination therapy with LDL apheresis, statins, and cholesterol absorption inhibitors in children with homozygous FH at the highest risk.
Peripheral blood stem cell transplantation (PBSCT), also called "Peripheral stem cell support", is a method of replacing blood-forming stem cells destroyed, for example, by cancer treatment. PBSCT is now a much more common procedure than its bone marrow harvest equivalent, this is in-part due to the ease and less invasive nature of the procedure. Studies suggest that PBSCT has a better outcome in terms of the number of hematopoietic stem cell (CD34+ cells) yield. Immature hematopoietic stem cells in the circulating blood that are similar to those in the bone marrow are collected by apheresis from a potential donor (PBSC collection).
His seminal contributions to research include being an author of the first paper to demonstrate vitamin D dysfunction and the importance of interleukin 6 in lupus, conducting the first large studies of apheresis in rheumatoid arthritis and lupus, and insights into the mechanisms of action of antimalarials. Wallace's research accomplishments also include conducting many clinical rheumatic disease trials, examining the role of microvascular angina and accelerated atherogenesis in lupus, and work on anti-telomere antibodies which have garnered him 5 papers in The New England Journal of Medicine. Wallace's monograph, The Lupus Book, has sold over 100,000 copies since 1995.
Bichon Frise The French word comes from Middle French ('small dog'), a diminutive of Old French ('female dog', cognate with English bitch), from Old English , and related to other Germanic words with the same meaning, including Old Norse , and German .Auguste Scheler, Dictionnaire d'étymologie française d'après les résultats de la science moderne, "bichon".Donkin, Diez, An etymological dictionary of the Romance languages, "biche". Some speculate the origin of to be the result of the apheresis, or shortening, of the word ('small poodle'), a derivative of ('shaggy dog'); however, this is likely impossible, since the word (attested 1588) is older than (attested 1694).
Blasi (1923), sub voce between Rome and Amatrice.The town was originally part of the Abruzzo Ultra Department of the Kingdom of the Two Sicilies, but was annexed to the Abruzzi Region of the Kingdom of Italy in 1861, and was finally incorporated into Lazio as part of the Province of Rieti when the latter was created in 1927. The recipe was extremely well received and rapidly went on to be considered a classic of Roman cuisine, even though it originated elsewhere. The name of the dish in the Romanesco dialect eventually became matriciana due to the apheresis typical of this dialect.
RBCs are mixed with an anticoagulant and storage solution which provides nutrients and aims to preserve viability and functionality of the cells (limiting their so-called "storage lesion"), which are stored at refrigerated temperatures for up to 42 days (in the US), except for the rather unusual long-term storage in which case they can be frozen for up to 10 years. The cells are separated from the fluid portion of the blood after it is collected from a donor, or during the collection process in the case of apheresis. The product is then sometimes modified after collection to meet specific patient requirements.
Grífols tried out the technique on himself, and, once he had confirmed that the technique was harmless, he practiced it on volunteer donors and gradually perfected it. He presented the results of his work in 1951 at the Fourth International Congress of Blood Transfusion in Lisbon, and in 1952 he published them in the British Medical Journal. Michael Rubinstein was the first to use plasmapheresis to treat an immune-related disorder when he "saved the life of an adolescent boy with thrombotic thrombocytopenic purpura (TTP) at the …Cedars of Lebanon Hospital in Los Angeles in 1959".Wallace, D.J. "Apheresis for lupus erythematosus".
Lexicographic changes in Medieval Greek influenced by Christianity can be found for instance in words like ('messenger') → heavenly messenger → angel) or 'love' → 'altruistic love', which is strictly differentiated from , ('physical love'). In everyday usage, some old Greek stems were replaced, for example, the expression for "wine" where the word ('mixture') replaced the old Greek . The word (meaning 'something you eat with bread') combined with the suffix , which was borrowed from the Latin , became 'fish' ( ), which after apheresis, synizesis and the loss of final became the new Greek and eliminated the Old Greek , which became an acrostic for Jesus Christ and a symbol for Christianity.
Treatment with a corticosteroid plus low-dose aspirin followed by maintenance therapy with an anabolic steroid where necessary are recommended for moderately severe cases. Very severe cases generally require an immunosuppressive drug regimen and if extreme or life-threatening require resorting to plasmaphoresis or plasma exchange. Cryofiltration apheresis, a method to remove plasma agents by removing cold-induced precipitated material, may be an effective alternative to plasmaphoresis and plasma exchange but is still regarded as second-line therapy for cryofibirnogenemic disease treatment. During the several years following its initial diagnosis, some 27-47% of primary cryofibrinoginemic diseases are complicated by the development of a B-cell or T-cell lymphoma.
In addition to its Vancouver facilities, STEMCELL has distribution and sales offices in the US, Europe, Australia and Singapore plus distributors in all other major countries. A spin-off company, STEMSOFT Software Inc, makes software for managing data in BMT centres, cord blood banks, cellular therapy companies and tumour/tissue repositories. A second spin-off, Malachite Management Inc, provides society and meeting management for such organizations as the Canadian Blood and Marrow Transplant Group, the International Society for Cell Therapy, the American Society for Apheresis and the Canadian Association of Oncology Nurses. In 2018 the STEMCELL Group had over 1,000 employees located in four facilities across the Lower Mainland.
Robert works with several professional societies and advisory boards. He is past-President of the Renal Physicians Association,Renal Physicians Association Board of Directors immediate past- Chair of the Board of Trustees for the National Kidney Foundation of Michigan, and an active member of the American Society of Nephrology and the American Society of Transplantation, and a fellow of the American College of Physicians. Provenzano is also a member of the Michigan State Medical Society, Wayne County Medical Society, American Medical Association, International Society of Nephrology, Transplant Society of Michigan, American Society of Apheresis, International Society of Peritoneoscopists, and International Society of Blood Purification.
Other racial, xenophobic, and spiteful terms and attitudes have developed against immigrants. Historically, "gallego" (Galician) for Spanish people in general, tano, an apheresis of napolitano (Napoletani, from Naples) for Italians, turco (Turkish) for immigrants from the Ottoman Empire and "ruso" (Russian) for Jewish immigrants from the Russian Empire and Europe were terms that carried pejorative connotations. These have to some extent carried over to the present, the former as jokes about Galicians and the latter as anti-Semitic insults."Ruso", Jergas del habla hispana Today, words such as "bolita", "paragua", and "boliguayo" constitute derogatory terms to refer to certain immigrants of other Latin American origin, mostly from neighboring countries like Bolivia and Paraguay.
Autologous HSCT requires the extraction (apheresis) of hematopoietic stem cells (HSCs) from the patient and storage of the harvested cells in a freezer. The patient is then treated with high-dose chemotherapy with or without radiotherapy with the intention of eradicating the patient's malignant cell population at the cost of partial or complete bone marrow ablation (destruction of patient's bone marrow's ability to grow new blood cells). The patient's own stored stem cells are then transfused into his/her bloodstream, where they replace destroyed tissue and resume the patient's normal blood-cell production. Autologous transplants have the advantage of lower risk of infection during the immune- compromised portion of the treatment, since the recovery of immune function is rapid.
Sometimes a person such as a cancer patient who requires routine transfusions of platelets will receive repeated donations from a specific donor to further minimize the risk. Pathogen reduction of platelets using for example, riboflavin and UV light treatments can also be carried out to reduce the infectious load of pathogens contained in donated blood products, thereby reducing the risk of transmission of transfusion transmitted diseases. Another photochemical treatment process utilizing amotosalen and UVA light has been developed for the inactivation of viruses, bacteria, parasites, and leukocytes that can contaminate blood components intended for transfusion. In addition, apheresis platelets tend to contain fewer contaminating red blood cells because the collection method is more efficient than "soft spin" centrifugation at isolating the desired blood component.

No results under this filter, show 131 sentences.

Copyright © 2024 RandomSentenceGen.com All rights reserved.